List view / Grid view

Entresto (sacubitril/valsartan)

Filter the results

 

news

NICE recommends heart failure drug Entresto

27 April 2016 | By Victoria White, Digital Content Producer

The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Entresto (sacubitril valsartan) for some people with heart failure.

news

EC grants marketing authorisation to Entresto

25 November 2015 | By Victoria White

The European Commission has granted marketing authorisation to Novartis’ Entresto (sacubitril/valsartan) for the treatment of adult patients with symptomatic chronic heart failure with reduced ejection fraction (HFrEF).

news

CHMP recommends heart failure drug Entresto

25 September 2015 | By Victoria White

The CHMP has adopted a positive opinion for Novartis’ Entresto (sacubitril/valsartan), marking an important milestone towards the drug becoming available in the EU.